TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler in Patients Aged 4 Through 11 Years With Persistent Asthma
Brief Summary: This study is to evaluate the safety and efficacy of fluticasone propionate and fluticasone propionate salmeterol in pediatric participants with a documented history of persistent asthma.


Options:
A: Arm Label: FLOVENT™ DISKUS™ 100 mcg; Type: ACTIVE_COMPARATOR; Interventions: Drug: FLOVENT™ DISKUS™ 100 mcg BID | Arm Label: ADVAIR™ DISKUS™ 100/50 mcg; Type: EXPERIMENTAL; Interventions: Drug: ADVAIR™ DISKUS™ 100/50 mcg BID | Intervention Type: DRUG; Name: FLOVENT™ DISKUS™ 100 mcg BID; Assigned to Arm(s): FLOVENT™ DISKUS™ 100 mcg | Intervention Type: DRUG; Name: ADVAIR™ DISKUS™ 100/50 mcg BID; Assigned to Arm(s): ADVAIR™ DISKUS™ 100/50 mcg
B: Arm Label: Vilanterol; Type: EXPERIMENTAL; Interventions: Drug: Vilanterol, Drug: Placebo Inhalation Powder Diskus | Arm Label: Salmeterol; Type: ACTIVE_COMPARATOR; Interventions: Drug: Salmeterol Inhalation Powder, Drug: Placebo Inhalation Powder NDPI | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo Inhalation Powder NDPI, Drug: Placebo Inhalation Powder Diskus | Intervention Type: DRUG; Name: Vilanterol; Assigned to Arm(s): Vilanterol | Intervention Type: DRUG; Name: Salmeterol Inhalation Powder; Assigned to Arm(s): Salmeterol | Intervention Type: DRUG; Name: Placebo Inhalation Powder NDPI; Assigned to Arm(s): Placebo, Salmeterol | Intervention Type: DRUG; Name: Placebo Inhalation Powder Diskus; Assigned to Arm(s): Placebo, Vilanterol
C: Arm Label: Placebo MDPI; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo MDPI | Arm Label: Fp MDPI 25 mcg BID; Type: EXPERIMENTAL; Interventions: Drug: Fluticasone Propionate | Arm Label: Fp MDPI 50 mcg BID; Type: EXPERIMENTAL; Interventions: Drug: Fluticasone Propionate | Arm Label: FS MDPI 50/12.5 mcg BID; Type: EXPERIMENTAL; Interventions: Drug: Fluticasone Propionate/Salmeterol | Intervention Type: DRUG; Name: Fluticasone Propionate; Assigned to Arm(s): Fp MDPI 25 mcg BID, Fp MDPI 50 mcg BID | Intervention Type: DRUG; Name: Fluticasone Propionate/Salmeterol; Assigned to Arm(s): FS MDPI 50/12.5 mcg BID | Intervention Type: DRUG; Name: Placebo MDPI; Assigned to Arm(s): Placebo MDPI
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Symbicort pMDI | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: budesonide pMDI | Intervention Type: DRUG; Name: Symbicort pMDI; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: budesonide pMDI; Assigned to Arm(s): 2

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Feasibility of a Home-based Transition Intervention to Reduce Sedentary Behaviour and Improve Function Within the First Six Months After Stroke: STand Up Frequently From Stroke Trial
Brief Summary: The traditional approach to physical activity promotion in people with stroke has always emphasized activities of a moderate-to-vigorous intensity (i.e. moving enough to breathe fast and break a sweat). For many people with stroke who often have difficulty with walking, achieving that intensity of activity is difficult. The result is that people with stroke spend over 80% of their day in sedentary behaviours (too much sitting). A growing body of research shows that too much sitting has negative effects on health including larger waist circumference, unhealthy levels of blood glucose and insulin, heart disease, lower levels of functioning, and premature death.

This project tests a new approach to activity promotion that focuses on increasing light-intensity activity throughout the whole day while reducing sitting time. The new intervention is titled "STand Up Frequently From Stroke (STUFFS)" and is aimed at increasing self-confidence among people with stroke to sit less, stand up and walk around at frequent intervals during the day. Studies in the general population have shown that standing up and walking around frequently are beneficially associated with health indicators (lower waist circumference, lower blood fat and glucose levels). Encouraging people with stroke to reduce sitting and increase light-intensity activities appears feasible and sustainable and might be a first step to increase their daily energy expenditure.


Options:
A: Arm Label: AARP; Type: N/A; Interventions: N/A
B: Arm Label: Experimental; Type: EXPERIMENTAL; Interventions: Other: Ballistic Strength Training | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual Care Physiotherapy | Intervention Type: OTHER; Name: Ballistic Strength Training; Assigned to Arm(s): Experimental | Intervention Type: OTHER; Name: Usual Care Physiotherapy; Assigned to Arm(s): Control
C: Arm Label: STUFFS; Type: EXPERIMENTAL; Interventions: Behavioral: Sedentary behaviour intervention | Intervention Type: BEHAVIORAL; Name: Sedentary behaviour intervention; Assigned to Arm(s): STUFFS
D: Arm Label: Virtual Reality Therapy; Type: EXPERIMENTAL; Interventions: Other: Virtual Reality | Arm Label: Traditional Therapy; Type: ACTIVE_COMPARATOR; Interventions: Other: Traditional Therapy | Intervention Type: OTHER; Name: Virtual Reality; Assigned to Arm(s): Virtual Reality Therapy | Intervention Type: OTHER; Name: Traditional Therapy; Assigned to Arm(s): Traditional Therapy

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Influence of Acute Bouts of Aerobic Exercise on Neuroplasticity and Motor Learning After Stroke
Brief Summary: Participants will complete 11 sessions. These include screening, 5 sessions where exercise or rest (according to group assignment) are paired with practice of a motor task, MRI and Transcranial Magnetic Stimulation (TMS) before and after the intervention will be used to assess neuroplasticity (ability for the brain to reorganize and create new connections).


Options:
A: Arm Label: Exercise + practice; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise, Behavioral: Practice | Arm Label: Rest + practice; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Practice | Intervention Type: BEHAVIORAL; Name: Exercise; Assigned to Arm(s): Exercise + practice | Intervention Type: BEHAVIORAL; Name: Practice; Assigned to Arm(s): Exercise + practice, Rest + practice
B: Arm Label: 1 session; Type: ACTIVE_COMPARATOR; Interventions: Other: Reactive balance training | Arm Label: 3 sessions; Type: EXPERIMENTAL; Interventions: Other: Reactive balance training | Arm Label: 6 sessions; Type: EXPERIMENTAL; Interventions: Other: Reactive balance training | Intervention Type: OTHER; Name: Reactive balance training; Assigned to Arm(s): 1 session, 3 sessions, 6 sessions
C: Arm Label: Variable high-intensity Training; Type: EXPERIMENTAL; Interventions: Behavioral: exercise | Arm Label: Variable low-intensity training; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: exercise | Arm Label: Constant High Intensity Training; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: exercise | Intervention Type: BEHAVIORAL; Name: exercise; Assigned to Arm(s): Constant High Intensity Training, Variable high-intensity Training, Variable low-intensity training
D: Arm Label: ArmAssist therapy; Type: EXPERIMENTAL; Interventions: Device: ArmAssist robotic training, Other: Conventional therapy | Arm Label: Conventional therapy; Type: ACTIVE_COMPARATOR; Interventions: Other: Conventional therapy | Arm Label: Extended Conventional therapy; Type: ACTIVE_COMPARATOR; Interventions: Other: Conventional therapy, Other: Extended conventional therapy | Intervention Type: DEVICE; Name: ArmAssist robotic training; Assigned to Arm(s): ArmAssist therapy | Intervention Type: OTHER; Name: Conventional therapy; Assigned to Arm(s): ArmAssist therapy, Conventional therapy, Extended Conventional therapy | Intervention Type: OTHER; Name: Extended conventional therapy; Assigned to Arm(s): Extended Conventional therapy

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: diEtitiaNs Helping pAtieNts CarE for Diabetes (ENHANCED)
Brief Summary: This study aims to randomly assign individuals with type 2 diabetes into the ENHANCED randomized control trial. The study is being conducted by the Minneapolis Heart Institute Foundation (MHIF) and will have two study sites 1) Hutchinson Health and 2) New Ulm Medical Center. The study is primarily funded through the Academy of Nutrition and Dietetics (AND).

The study will examine the impact of a registered dietitian-led, primary care integrated, telemedicine program on diabetes care measures (the 'D5') over one year as compared to usual care. The D5 goals include: blood pressure \<140/90 mmHg, taking a statin as appropriate, A1c \<8%, not using tobacco and taking an aspirin as appropriate.


Options:
A: Arm Label: mWELLCARE software arm; Type: EXPERIMENTAL; Interventions: Other: mWELLCARE | Arm Label: Usual care arm; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual Care | Intervention Type: OTHER; Name: mWELLCARE; Assigned to Arm(s): mWELLCARE software arm | Intervention Type: OTHER; Name: Usual Care; Assigned to Arm(s): Usual care arm
B: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Coaching | Arm Label: Standard of Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Coaching; Assigned to Arm(s): Intervention
C: Intervention Type: BEHAVIORAL; Name: Resistance Training; Assigned to Arm(s): N/A
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Health coaching | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Health coaching; Assigned to Arm(s): 1

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Myocardial Ischemia and Transfusion
Brief Summary: The purpose of this study is to compare two red blood cell transfusion strategies (liberal and restrictive) for patients who have had an acute myocardial infarction and are anemic.


Options:
A: Arm Label: Liberal Transfusion Strategy; Type: EXPERIMENTAL; Interventions: Biological: Red blood cell transfusion | Arm Label: Restrictive transfusion strategy; Type: EXPERIMENTAL; Interventions: Biological: Red blood cell transfusion | Intervention Type: BIOLOGICAL; Name: Red blood cell transfusion; Assigned to Arm(s): Liberal Transfusion Strategy, Restrictive transfusion strategy
B: Arm Label: "liberal" transfusion triggers; Type: EXPERIMENTAL; Interventions: Other: red blood cell transfusion | Arm Label: "restrictive" transfusion triggers; Type: ACTIVE_COMPARATOR; Interventions: Other: red blood cell transfusion | Intervention Type: OTHER; Name: red blood cell transfusion; Assigned to Arm(s): "liberal" transfusion triggers | Intervention Type: OTHER; Name: red blood cell transfusion; Assigned to Arm(s): "restrictive" transfusion triggers
C: Arm Label: Liberal Transfusion Strategy; Type: ACTIVE_COMPARATOR; Interventions: Biological: Red Blood Cell Transfusion | Arm Label: Restrictive Transfusion Strategy; Type: ACTIVE_COMPARATOR; Interventions: Biological: Red Blood Cell Transfusion | Intervention Type: BIOLOGICAL; Name: Red Blood Cell Transfusion; Assigned to Arm(s): Liberal Transfusion Strategy, Restrictive Transfusion Strategy
D: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Packed Red Blood Cell Transfusion | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Procedure: Packed Red Blood Cell Transfusion | Intervention Type: PROCEDURE; Name: Packed Red Blood Cell Transfusion; Assigned to Arm(s): 1, 2

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Myocardial Ischemia and Transfusion
Brief Summary: The purpose of this study is to compare two red blood cell transfusion strategies (liberal and restrictive) for patients who have had an acute myocardial infarction and are anemic.


Options:
A: Arm Label: Liberal Transfusion Strategy; Type: ACTIVE_COMPARATOR; Interventions: Biological: Red Blood Cell Transfusion | Arm Label: Restrictive Transfusion Strategy; Type: ACTIVE_COMPARATOR; Interventions: Biological: Red Blood Cell Transfusion | Intervention Type: BIOLOGICAL; Name: Red Blood Cell Transfusion; Assigned to Arm(s): Liberal Transfusion Strategy, Restrictive Transfusion Strategy
B: Arm Label: Restrictive Transfusion Strategy; Type: ACTIVE_COMPARATOR; Interventions: Other: Restrictive Transfusion Strategy | Arm Label: Liberal Transfusion Strategy; Type: ACTIVE_COMPARATOR; Interventions: Other: Liberal transfusion strategy | Intervention Type: OTHER; Name: Restrictive Transfusion Strategy; Assigned to Arm(s): Restrictive Transfusion Strategy | Intervention Type: OTHER; Name: Liberal transfusion strategy; Assigned to Arm(s): Liberal Transfusion Strategy
C: Arm Label: Liberal blood transfusion; Type: ACTIVE_COMPARATOR; Interventions: Biological: SAGM (Saline-Adenine-Glucose-Mannitol) blood transfusion | Arm Label: Restrictive blood transfusion; Type: ACTIVE_COMPARATOR; Interventions: Biological: SAGM (Saline-Adenine-Glucose-Mannitol) blood transfusion | Intervention Type: BIOLOGICAL; Name: SAGM (Saline-Adenine-Glucose-Mannitol) blood transfusion; Assigned to Arm(s): Liberal blood transfusion | Intervention Type: BIOLOGICAL; Name: SAGM (Saline-Adenine-Glucose-Mannitol) blood transfusion; Assigned to Arm(s): Restrictive blood transfusion
D: Arm Label: Restrictive transfusion strategy; Type: ACTIVE_COMPARATOR; Interventions: Other: Restrictive Transfusion Strategy | Arm Label: Liberal transfusion strategy; Type: ACTIVE_COMPARATOR; Interventions: Other: Liberal transfusion strategy | Intervention Type: OTHER; Name: Restrictive Transfusion Strategy; Assigned to Arm(s): Restrictive transfusion strategy | Intervention Type: OTHER; Name: Liberal transfusion strategy; Assigned to Arm(s): Liberal transfusion strategy

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Myocardial Ischemia and Transfusion
Brief Summary: The purpose of this study is to compare two red blood cell transfusion strategies (liberal and restrictive) for patients who have had an acute myocardial infarction and are anemic.


Options:
A: Arm Label: Liberal Transfusion Strategy; Type: ACTIVE_COMPARATOR; Interventions: Biological: Red Blood Cell Transfusion | Arm Label: Restrictive Transfusion Strategy; Type: ACTIVE_COMPARATOR; Interventions: Biological: Red Blood Cell Transfusion | Intervention Type: BIOLOGICAL; Name: Red Blood Cell Transfusion; Assigned to Arm(s): Liberal Transfusion Strategy, Restrictive Transfusion Strategy
B: Arm Label: Restrictive Transfusion Strategy; Type: ACTIVE_COMPARATOR; Interventions: Other: Restrictive Transfusion Strategy | Arm Label: Liberal Transfusion Strategy; Type: ACTIVE_COMPARATOR; Interventions: Other: Liberal transfusion strategy | Intervention Type: OTHER; Name: Restrictive Transfusion Strategy; Assigned to Arm(s): Restrictive Transfusion Strategy | Intervention Type: OTHER; Name: Liberal transfusion strategy; Assigned to Arm(s): Liberal Transfusion Strategy
C: Arm Label: Liberal Group; Type: EXPERIMENTAL; Interventions: Other: Haemoglobin 9.5 g/dL | Arm Label: Restrictive group; Type: ACTIVE_COMPARATOR; Interventions: Other: Haemoglobine 7.5g/dL | Intervention Type: OTHER; Name: Haemoglobin 9.5 g/dL; Assigned to Arm(s): Liberal Group | Intervention Type: OTHER; Name: Haemoglobine 7.5g/dL; Assigned to Arm(s): Restrictive group
D: Arm Label: Blood transfusion; Type: EXPERIMENTAL; Interventions: Biological: Blood transfusion | Intervention Type: BIOLOGICAL; Name: Blood transfusion; Assigned to Arm(s): Blood transfusion

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Multi-center Randomised Controlled Trial to Explore the Ideal Initial Enteral Feeding Strategies in Patients With Severe Stroke at Acute Stage
Brief Summary: The purpose of this academic lead study is to explore the ideal nutritional support strategy for patient with acute severe stroke.


Options:
A: Arm Label: Early enteral nutrition; Type: EXPERIMENTAL; Interventions: Drug: early enteral nutrition | Arm Label: Delayed enteral nutrition; Type: ACTIVE_COMPARATOR; Interventions: Drug: Delayed enteral nutrition | Intervention Type: DRUG; Name: early enteral nutrition; Assigned to Arm(s): Early enteral nutrition | Intervention Type: DRUG; Name: Delayed enteral nutrition; Assigned to Arm(s): Delayed enteral nutrition
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Minimal (Trophic) Feeding, Dietary Supplement: Omega-3 Fatty Acids and Antioxidant Supplements | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: Full Feeding, Dietary Supplement: Omega-3 Fatty Acids and Antioxidant Supplements | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Behavioral: Minimal (Trophic) Feeding, Dietary Supplement: Placebo | Arm Label: 4; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Full Feeding, Dietary Supplement: Placebo | Intervention Type: BEHAVIORAL; Name: Minimal (Trophic) Feeding; Assigned to Arm(s): 1, 3 | Intervention Type: BEHAVIORAL; Name: Full Feeding; Assigned to Arm(s): 2, 4 | Intervention Type: DIETARY_SUPPLEMENT; Name: Omega-3 Fatty Acids and Antioxidant Supplements; Assigned to Arm(s): 1, 2 | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): 3, 4
C: Arm Label: EN only; Type: EXPERIMENTAL; Interventions: Other: Withholding PN during the first week of ICU stay | Arm Label: EN plus early PN; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oliclinomel N71000 OR N71000E // Clinimix N17G35 OR N17G35E | Intervention Type: OTHER; Name: Withholding PN during the first week of ICU stay; Assigned to Arm(s): EN only | Intervention Type: DRUG; Name: Oliclinomel N71000 OR N71000E // Clinimix N17G35 OR N17G35E; Assigned to Arm(s): EN plus early PN
D: Arm Label: Full enteral feeding; Type: ACTIVE_COMPARATOR; Interventions: Other: Initial enteral feeding | Arm Label: Modified full enteral feeding; Type: EXPERIMENTAL; Interventions: Other: Initial enteral feeding, Drug: metoclopramide or mosapride | Arm Label: Permissive underfeeding; Type: EXPERIMENTAL; Interventions: Other: Initial enteral feeding | Intervention Type: OTHER; Name: Initial enteral feeding; Assigned to Arm(s): Full enteral feeding, Modified full enteral feeding, Permissive underfeeding | Intervention Type: DRUG; Name: metoclopramide or mosapride; Assigned to Arm(s): Modified full enteral feeding

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: At all of the follow-ups, including the worst period (between four and ten weeks), the intervention group reported higher scores than the control group, suggesting in this RCT that adopting the person-centred-care concept was a promising way to improve function and wellbeing in patients with HNC.


Options:
A: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: Reflexology | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Reflexology; Assigned to Arm(s): Intervention
B: Arm Label: Interdisciplinary rehabilitation; Type: EXPERIMENTAL; Interventions: Behavioral: Interdisciplinary rehabilitation | Arm Label: Care as usual; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Interdisciplinary rehabilitation; Assigned to Arm(s): Interdisciplinary rehabilitation
C: Arm Label: Bone marrow transplantation; Type: OTHER; Interventions: Procedure: Bone marrow transplantation | Arm Label: Peripheral blood stem cell transplantation; Type: OTHER; Interventions: Procedure: Peripheral blood stem cell transplantation | Intervention Type: PROCEDURE; Name: Bone marrow transplantation; Assigned to Arm(s): Bone marrow transplantation | Intervention Type: PROCEDURE; Name: Peripheral blood stem cell transplantation; Assigned to Arm(s): Peripheral blood stem cell transplantation
D: Arm Label: gPCC-G (Gothenburg Person Centred Care) Group; Type: EXPERIMENTAL; Interventions: Other: gPCC (Gothenburg Person Centred Care) | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: gPCC (Gothenburg Person Centred Care); Assigned to Arm(s): gPCC-G (Gothenburg Person Centred Care) Group

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Analgesia For Positioning Patient With Femur Fracture For Spinal Anaesthesia : Ultrasound-Guided Fascia Iliaca Compartment Block Versus Intravenous Fentanyl
Brief Summary: This study is performed to determine the efficacy of ultrasound-guided fascia iliaca compartment block during positioning for spinal anaesthesia in patient undergoing repair of proximal femur fracture surgery comparing with intravenous fentanyl.


Options:
A: Arm Label: Exparel (Liposomal Bupivacaine); Type: EXPERIMENTAL; Interventions: Drug: Exparel | Arm Label: Saline Control; Type: PLACEBO_COMPARATOR; Interventions: Drug: Sodium Chloride | Intervention Type: DRUG; Name: Exparel; Assigned to Arm(s): Exparel (Liposomal Bupivacaine) | Intervention Type: DRUG; Name: Sodium Chloride; Assigned to Arm(s): Saline Control
B: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo, Device: Ultrasound guided fascia iliaca compartment block, Drug: Intrathecal medications (bupivacaine (15 mg) in conjunction with fentanyl 20 micrograms) | Arm Label: Bupivacaine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Bupivacaine, Device: Ultrasound guided fascia iliaca compartment block, Drug: Intrathecal medications (bupivacaine (15 mg) in conjunction with fentanyl 20 micrograms) | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Bupivacaine; Assigned to Arm(s): Bupivacaine | Intervention Type: DEVICE; Name: Ultrasound guided fascia iliaca compartment block; Assigned to Arm(s): Bupivacaine, Placebo | Intervention Type: DRUG; Name: Intrathecal medications (bupivacaine (15 mg) in conjunction with fentanyl 20 micrograms); Assigned to Arm(s): Bupivacaine, Placebo
C: Arm Label: Standard Treatment; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Continuous fascia iliaca block; Type: EXPERIMENTAL; Interventions: Procedure: Continuous fascia iliaca block, Drug: Ropivacaine | Intervention Type: PROCEDURE; Name: Continuous fascia iliaca block; Assigned to Arm(s): Continuous fascia iliaca block | Intervention Type: DRUG; Name: Ropivacaine; Assigned to Arm(s): Continuous fascia iliaca block
D: Arm Label: fascia iliaca compartment block; Type: ACTIVE_COMPARATOR; Interventions: Drug: Ropivacaine, Device: Ultrasound | Arm Label: intravenous fentanyl; Type: ACTIVE_COMPARATOR; Interventions: Drug: Fentanyl | Intervention Type: DRUG; Name: Ropivacaine; Assigned to Arm(s): fascia iliaca compartment block | Intervention Type: DRUG; Name: Fentanyl; Assigned to Arm(s): intravenous fentanyl | Intervention Type: DEVICE; Name: Ultrasound; Assigned to Arm(s): fascia iliaca compartment block

Answer: D